HGH Frag 176-191

Description

HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone studied for lipolytic activity without the growth-promoting effects of full-length hGH. For laboratory research use only.

HGH Fragment 176-191 corresponds to the final 16 amino acids of the human growth hormone molecule, a region associated with the hormone's fat-metabolizing activity. In preclinical research it has been investigated for its ability to stimulate lipolysis and inhibit lipogenesis in adipose tissue while showing little effect on IGF-1 levels, insulin sensitivity, or skeletal growth pathways. This selectivity has made it a subject of interest in metabolic and body-composition research models. Supplied as a lyophilized powder for in-vitro and laboratory research use only; not for human consumption.

This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 5mg of research-grade material.

Research Applications

• Lipolysis and fat metabolism research
• Body composition studies
• Growth hormone fragment signaling
• Metabolic research models

Specifications

Size

5mg

Purity

≥98% (HPLC)

Form

Lyophilized Powder

Molecular Formula

C78H125N23O23S2

Molecular Weight

1817.1 g/mol

CAS Number

66004-57-7

Storage & Handling

• Long-term storage: -20°C in a sealed, light-protected container
• Short-term storage: 2-8°C (refrigerated) for up to 30 days
• Reconstituted: Store at 2-8°C and use within 30 days
• Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
• Reconstitution: Use bacteriostatic water or sterile water for injection